Millennium Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.69M | Buy |
478,557
+173,780
| +57% | +$1.27M | ﹤0.01% | 3272 |
|
|
2025
Q4 | $1.87M | Buy |
304,777
+264,977
| +666% | +$2.86M | ﹤0.01% | 4003 |
|
|
2025
Q3 | $734K | Buy |
+39,800
| New | +$639K | ﹤0.01% | 4845 |
|
|
2025
Q2 | – | Sell |
-461,907
| Closed | -$4.89M | – | 5850 |
|
|
2025
Q1 | $4.89M | Buy |
+461,907
| New | +$7.33M | ﹤0.01% | 2885 |
|
|
2024
Q4 | – | Sell |
-236,073
| Closed | -$5.48M | – | 5944 |
|
|
2024
Q3 | $5.48M | Sell |
236,073
-318,951
| -57% | -$6.82M | ﹤0.01% | 2760 |
|
|
2024
Q2 | $13.5M | Buy |
555,024
+396,505
| +250% | +$12M | 0.01% | 1828 |
|
|
2024
Q1 | $5.35M | Buy |
158,519
+24,859
| +19% | +$881K | ﹤0.01% | 2799 |
|
|
2023
Q4 | $4.21M | Buy |
133,660
+56,297
| +73% | +$1.34M | ﹤0.01% | 2925 |
|
|
2023
Q3 | $1.98M | Buy |
77,363
+65,599
| +558% | +$2.02M | ﹤0.01% | 3557 |
|
|
2023
Q2 | $337K | Sell |
11,764
-91,647
| -89% | -$2.49M | ﹤0.01% | 4810 |
|
|
2023
Q1 | $2.48M | Buy |
103,411
+62,024
| +150% | +$1.11M | ﹤0.01% | 3229 |
|
|
2022
Q4 | $702K | Buy |
41,387
+22,926
| +124% | +$400K | ﹤0.01% | 4477 |
|
|
2022
Q3 | $274K | Sell |
18,461
-186,135
| -91% | -$3.12M | ﹤0.01% | 5448 |
|
|
2022
Q2 | $3.22M | Buy |
+204,596
| New | +$4.01M | ﹤0.01% | 3226 |
|
|
2021
Q4 | – | Sell |
-89,075
| Closed | -$4.26M | – | 6752 |
|
|
2021
Q3 | $4.26M | Buy |
+89,075
| New | +$3.99M | 0.01% | 3048 |
|
|
2021
Q2 | – | Sell |
-105,138
| Closed | -$4.34M | – | 6496 |
|
|
2021
Q1 | $4.34M | Buy |
105,138
+74,273
| +241% | +$4.43M | 0.01% | 2735 |
|
|
2020
Q4 | $1.34M | Buy |
+30,865
| New | +$2.09M | ﹤0.01% | 3530 |
|
|
2020
Q3 | – | Sell |
-6,276
| Closed | -$293K | – | 4415 |
|
|
2020
Q2 | $293K | Sell |
6,276
-94,000
| -94% | -$3.24M | ﹤0.01% | 3670 |
|
|
2020
Q1 | $1.36M | Buy |
+100,276
| New | +$1.28M | 0.01% | 2275 |
|
|
2017
Q1 | – | Sell |
-6,221
| Closed | -$91K | – | 3466 |
|
|
2016
Q4 | $91K | Sell |
6,221
-4,379
| -41% | -$65.5K | ﹤0.01% | 3205 |
|
|
2016
Q3 | $183K | Buy |
+10,600
| New | +$342K | ﹤0.01% | 3002 |
|
|
2016
Q2 | – | Sell |
-3,261
| Closed | -$87K | – | 3153 |
|
|
2016
Q1 | $87K | Buy |
+3,261
| New | +$110K | ﹤0.01% | 3103 |
|
|
2015
Q4 | – | Sell |
-3,354
| Closed | -$142K | – | 3395 |
|
|
2015
Q3 | $142K | Buy |
+3,354
| New | +$176K | ﹤0.01% | 3207 |
|
|
2015
Q1 | – | Sell |
-33,043
| Closed | -$863K | – | 3552 |
|
|
2014
Q4 | $863K | Buy |
33,043
+18,230
| +123% | +$580K | ﹤0.01% | 2596 |
|
|
2014
Q3 | $1.6M | Buy |
14,813
+12,536
| +551% | +$1.63M | ﹤0.01% | 2017 |
|
|
2014
Q2 | $276K | Sell |
2,277
-642
| -22% | -$77.5K | ﹤0.01% | 2923 |
|
|
2014
Q1 | $371K | Buy |
+2,919
| New | +$433K | ﹤0.01% | 2814 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
